Back to Search Start Over

THE HEMATOPOIETIC CELL TRANSPLANTATION-SPECIFIC COMORBIDITY INDEX (HCT-CI) PREDICTS SURVIVAL AND NON-RELAPSE MORTALITY IN LYMPHOMA AND MYELOMA PATIENTS RECEIVING RIC ALLOGRAFT

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.od.......970..753fbd797083e2dfbcd0e6ffae14f2d4